INDIANAPOLIS, IN — This evening, the U.S. Supreme Court issued a decision to preserve the use of mifepristone. The Court ruled that access to mifepristone should remain unchanged while Alliance for Hippocratic Medicine v. FDA moves through lower courts. This decision reverses lower court decisions in recent weeks that attempted to remove or restrict access to mifepristone.
Statement by Rebecca Gibron, CEO of Planned Parenthood Great Northwest, Hawai’i, Alaska, Indiana, Kentucky:
“Decisions regarding health care and medication need to be made between doctors and patients – not by activist judges with no medical expertise. For over 20 years, mifepristone has helped expand access to abortion care, allowing patients to make their own private medical decisions. We are thrilled to continue providing mifepristone to our patients.
“But I want to be clear: anti-abortion extremists will not stop here. They will continue to push these bogus claims and will find other opportunities to use extremist judges to advance their goal of a nationwide abortion ban. We will stay vigilant. We will never stop fighting for our right to control our bodies and our futures. And we will never stop providing safe, legal abortion care in Indiana.”
Additional information on mifepristone:
Mifepristone is used in more than half of abortion procedures nationwide. It is safe, effective, and has been used by more than 5 million people since the FDA approved it more than 20 years ago. There is overwhelming evidence that medication abortion is safe and effective for virtually anyone who wants to end an early pregnancy. Still, access to mifepristone is under attack by extreme minorities who care more about controlling your reproductive choices than they do about science and medicine.
Our Planned Parenthood health centers in Indiana are ready to provide care, and our patient navigators are available to answer patient questions about how this case may affect them. Anyone who needs care should call 1-800-230-7526. Patient navigators are ready to help.
